819 related articles for article (PubMed ID: 19048205)
1. Antiviral resistance and impact on viral replication capacity: evolution of viruses under antiviral pressure occurs in three phases.
Nijhuis M; van Maarseveen NM; Boucher CA
Handb Exp Pharmacol; 2009; (189):299-320. PubMed ID: 19048205
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus mutations associated with antiviral therapy.
Bartholomeusz A; Locarnini S
J Med Virol; 2006; 78 Suppl 1():S52-5. PubMed ID: 16622878
[TBL] [Abstract][Full Text] [Related]
3. Resistance mechanisms in HCV: from evolution to intervention.
Kim AY; Timm J
Expert Rev Anti Infect Ther; 2008 Aug; 6(4):463-78. PubMed ID: 18662114
[TBL] [Abstract][Full Text] [Related]
4. Major causes of antiviral drug resistance and implications for treatment of hepatitis B virus monoinfection and coinfection with HIV.
Locarnini S; Warner N
Antivir Ther; 2007; 12 Suppl 3():H15-23. PubMed ID: 18284179
[TBL] [Abstract][Full Text] [Related]
5. Understanding hepatitis C viral dynamics with direct-acting antiviral agents due to the interplay between intracellular replication and cellular infection dynamics.
Guedj J; Neumann AU
J Theor Biol; 2010 Dec; 267(3):330-40. PubMed ID: 20831874
[TBL] [Abstract][Full Text] [Related]
6. A perspective on antiviral resistance.
Griffiths PD
J Clin Virol; 2009 Sep; 46(1):3-8. PubMed ID: 19615937
[TBL] [Abstract][Full Text] [Related]
7. Comparison of antiviral resistance across acute and chronic viral infections.
Mason S; Devincenzo JP; Toovey S; Wu JZ; Whitley RJ
Antiviral Res; 2018 Oct; 158():103-112. PubMed ID: 30086337
[TBL] [Abstract][Full Text] [Related]
8. Antiviral drug resistance.
Richman DD
Antiviral Res; 2006 Sep; 71(2-3):117-21. PubMed ID: 16621040
[TBL] [Abstract][Full Text] [Related]
9. Evolution of the susceptibility to antiviral drugs of A/H3N2 influenza viruses isolated in France from 2002 to 2005.
Ferraris O; Kessler N; Valette M; Lina B
Vaccine; 2006 Nov; 24(44-46):6656-9. PubMed ID: 16797804
[TBL] [Abstract][Full Text] [Related]
10. Resistance to anti-influenza drugs: adamantanes and neuraminidase inhibitors.
Hurt AC; Ho HT; Barr I
Expert Rev Anti Infect Ther; 2006 Oct; 4(5):795-805. PubMed ID: 17140356
[TBL] [Abstract][Full Text] [Related]
11. Mode of selection and experimental evolution of antiviral drugs resistance in vesicular stomatitis virus.
Cuevas JM; Sanjuán R; Moya A; Elena SF
Infect Genet Evol; 2005 Jan; 5(1):55-65. PubMed ID: 15567139
[TBL] [Abstract][Full Text] [Related]
12. Mutations conferring zanamivir resistance in human influenza virus N2 neuraminidases compromise virus fitness and are not stably maintained in vitro.
Zürcher T; Yates PJ; Daly J; Sahasrabudhe A; Walters M; Dash L; Tisdale M; McKimm-Breschkin JL
J Antimicrob Chemother; 2006 Oct; 58(4):723-32. PubMed ID: 16891631
[TBL] [Abstract][Full Text] [Related]
13. Mutations affecting the replication capacity of the hepatitis B virus.
Sheldon J; Rodès B; Zoulim F; Bartholomeusz A; Soriano V
J Viral Hepat; 2006 Jul; 13(7):427-34. PubMed ID: 16792535
[TBL] [Abstract][Full Text] [Related]
14. Surveillance for neuraminidase-inhibitor-resistant influenza viruses in Japan, 1996-2007.
Tashiro M; McKimm-Breschkin JL; Saito T; Klimov A; Macken C; Zambon M; Hayden FG;
Antivir Ther; 2009; 14(6):751-61. PubMed ID: 19812437
[TBL] [Abstract][Full Text] [Related]
15. [Function of neuraminidase of influenza virus and anti influenza compounds by its inhibition].
Yamashita M
Tanpakushitsu Kakusan Koso; 2009 Aug; 54(10):1284-91. PubMed ID: 19663256
[No Abstract] [Full Text] [Related]
16. RNA virus quasispecies: significance for viral disease and epidemiology.
Duarte EA; Novella IS; Weaver SC; Domingo E; Wain-Hobson S; Clarke DK; Moya A; Elena SF; de la Torre JC; Holland JJ
Infect Agents Dis; 1994 Aug; 3(4):201-14. PubMed ID: 7827789
[TBL] [Abstract][Full Text] [Related]
17. Pyrosequencing as a tool to detect molecular markers of resistance to neuraminidase inhibitors in seasonal influenza A viruses.
Deyde VM; Okomo-Adhiambo M; Sheu TG; Wallis TR; Fry A; Dharan N; Klimov AI; Gubareva LV
Antiviral Res; 2009 Jan; 81(1):16-24. PubMed ID: 18835410
[TBL] [Abstract][Full Text] [Related]
18. Minority report: hidden memory genomes in HIV-1 quasispecies and possible clinical implications.
Briones C; Domingo E
AIDS Rev; 2008; 10(2):93-109. PubMed ID: 18615120
[TBL] [Abstract][Full Text] [Related]
19. Antiviral-resistant hepatitis B virus: can we prevent this monster from growing?
Zoulim F; Buti M; Lok AS
J Viral Hepat; 2007 Nov; 14 Suppl 1():29-36. PubMed ID: 17958640
[TBL] [Abstract][Full Text] [Related]
20. In vitro characterization of viral fitness of therapy-resistant hepatitis B variants.
Villet S; Billioud G; Pichoud C; Lucifora J; Hantz O; Sureau C; Dény P; Zoulim F
Gastroenterology; 2009 Jan; 136(1):168-176.e2. PubMed ID: 18996386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
